MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, JUNS made $18,652 in revenue. -$2,061,958 in net income. Net profit margin of -11054.89%.

Income Overview

Revenue
$18,652
Net Income
-$2,061,958
Net Profit Margin
-11054.89%
EPS
-$0.06
Unit: Dollar

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Product revenues, net
18,652 5,449* --
Cost of goods sold
4,362 1,057.75* --
Gross profit
14,290 4,391.25* --
Research and development
411,049 -277,643.5* 816,697 759,448
General and administrative
1,566,241 2,347,856.25* 1,480,356 1,505,432
Total operating expenses
1,977,290 2,070,212.75* 2,297,053 2,264,880
Operating loss
-1,963,000 -2,065,821.5* -2,297,053 -2,264,880
Other income
-47,912* -0
Interest income
18,404 -10,212 13,050
Gain on change in fair value of convertible notes
1,282 247,039* --
Interest expense
118,644 62,528* 1,193 1,135
Gain on extinguishment of debt
---0
Loss on change in fair value of derivative liability
---0
Total other expenses, net
-98,958 232,423* 9,019 11,915
Net loss
-2,061,958 -1,833,398.5 -2,288,034 -2,252,965
Basic EPS
-0.06 -0.05 -0.07 -0.07
Diluted EPS
-0.06 -0.05 -0.07 -0.07
Basic Average Shares
35,255,588 36,664,892 34,039,906 33,180,966
Diluted Average Shares
35,255,588 36,664,892 34,039,906 33,180,966
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$2,061,958 Product revenues, net$18,652 Operating loss-$1,963,000 Total other expenses,net-$98,958 Gross profit$14,290 Interest income$18,404 Gain on change in fairvalue of convertible...$1,282 Cost of goods sold$4,362 Total operatingexpenses$1,977,290 Interest expense$118,644 General andadministrative$1,566,241 Research and development$411,049

JUPITER NEUROSCIENCES, INC. (JUNS)

JUPITER NEUROSCIENCES, INC. (JUNS)